Patents by Inventor Eric THOUVENOT

Eric THOUVENOT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210364533
    Abstract: A method for diagnosing or prognosing, multiple sclerosis including the steps of (a) measuring the amount of at least one first protein as set forth in SEQ ID NO: 1, the at least first protein belonging to the group of proteins: a first protein, a second protein, a third protein, a fourth protein and a fifth protein, as set forth in SEQ ID NO 1 to 5, (b) comparing the amount of the at least first protein with the amount of the same protein in a control sample, and (c) determining the status of the biological sample.
    Type: Application
    Filed: May 22, 2019
    Publication date: November 25, 2021
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICAL (INSERM), UNIVERSITE DE MONTPELLIER, CENTRE HOSPITALIER UNIVERSITAIRE DE NÎMES
    Inventors: Eric THOUVENOT, Philippe MARIN, Serge URBACH, Geoffrey HINSINGER
  • Publication number: 20160018416
    Abstract: A new dual biomarker of neurodegeneration and of neuroregeneration
    Type: Application
    Filed: February 22, 2013
    Publication date: January 21, 2016
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ECOLE NORMALE SUPERIEURE, COLLEGE DE FRANCE
    Inventors: Philippe MARIN, Eric THOUVENOT, Genevieve NGUYEN, Matthias GROSZER